Watch Ticker

Terns Pharmaceuticals, Inc. Common Stock

Go to Terns Pharmaceuticals, Inc. Common Stock Website

$5.99

0.24 (4.17%)

Live

Previous Close

$5.75

Day Range

$5.63 - $6.09

Previous Day Range

$5.4 - $5.885

Market Cap

$477.7 million USD

Day Vol.

518306

Previous Day Vol.

1.3 million

Currency

USD

Primary Exchange

Nasdaq

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chron...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

David Jagielski - This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments

Terns Pharmaceuticals has a promising GLP-1 weight-loss drug that could compete with treatments from Novo Nordisk and Eli Lilly. However, the company is still in early stages and faces risks, including the need for ongoing stock offerings to fund its cash-burning operations.

Related tickers: TERN, NVO, LLY.

Read Full Article

Alex Carchidi - Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.

Terns Pharmaceuticals, a pre-revenue weight loss biotech company, is worth considering as its lead candidate TERN-601 has shown promising phase 1 results, suggesting it could be competitive with other weight loss drugs on the market.

Related tickers: VKTX, TERN, LLY, NVO.

Read Full Article

Trending Tickers

Please sign in to view